ENTITY

SMARTSCORE: 3.4/5

Ascletis Pharma Inc (1672 HK)

71

Analysis

Health Care • China

Ascletis Pharma Inc. operates as a biotechnology company. The Company develops and discovers anti-viral drugs to address unmet medical needs in anti-viral, cancer, and fatty liver disease. Ascletis Pharma offers its services worldwide.

more

Refresh

Exchange Announcement • 13 Mar 2025 08:34

Notice Of Board Meeting

Exchange Announcement • 11 Mar 2025 23:15

Inside Information - Ascletis Announces Positive Topline Results Of Phase Ib Studies Of Asc47 Monotherapy In Australia And U.S. Fda Clearance Of Ind Application For Asc47 In Combination With Semaglutide

Exchange Announcement • 19 Feb 2025 11:45

Inside Information - Ascletis Announces Positive Interim Results From First Two Cohorts Of U.S. Phase Ib Multiple Ascending Dose Study Of Small Molecule Oral Glp-1r Agonist Asc30

Exchange Announcement • 13 Feb 2025 12:59

Next Day Disclosure Return

Exchange Announcement • 03 Feb 2025 11:58

Poll Results Of The Extraordinary General Meeting Held On February 3, 2025

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.49.0

x